Rating History for Mural Oncology (MURA) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2025 Judah Frommer Downgrade Equalweight
(Overweight)
N/A
(N/A)
3.83
(2.04)
-46.74% Details